Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard M Gebel

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Transplantation|November 24, 2021
Belatacept in Kidney Transplant Recipients With Failed Allografts for the Prevention of Humoral Sensitization: A Pilot Randomized Controlled TrialI Raul Badell, Robert A Bray, Rivka Elbein, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 4, 2016
Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive AntibodiesHoward M Gebel, Bertram L Kasiske, Sally K Gustafson, et al.
Clinical Transplantation|February 2, 2022
Immunogenicity after heterologous third dose COVID-19 vaccination in a heart transplant recipientSapna A Mehta, Alex Reyentovich, Robert A Montgomery, et al.
Transplant Immunology|September 24, 2022
Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipientsThomas R McCune, Robert A Bray, David A Baran, et al.
Archives of Pathology & Laboratory Medicine|February 25, 2017
Genotyping Applications for Transplantation and Transfusion Management: The Emory ExperienceRoss M Fasano, Harold Cliff Sullivan, Robert A Bray, et al.
Transplantation|April 16, 2004
Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokineticsCarlos A Vieira, Avinash Agarwal, Benita K Book, et al.
Transplantation|September 7, 2022
Analysis of Cross-sectional and Longitudinal HLA and Anti-viral Responses After COVID Infection in Renal Allograft Recipients: Differences and CorrelatesAlin L Girnita, Lin Wang, Adriana I Colovai, et al.
Kidney International|February 16, 2020
Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant lossRuth Sapir-Pichhadze, Xun Zhang, Abdelhakim Ferradji, et al.
Transplantation Direct|July 17, 2023
Detailed Analysis of Simultaneous Renal and Liver Allografts in the Presence of DSAJacqueline G O'Leary, Alton B Farris, Howard M Gebel, et al.
Frontiers in Immunology|December 12, 2022
Dissecting the impact of molecular T-cell HLA mismatches in kidney transplant failure: A retrospective cohort studyWilliam Lemieux, David Fleischer, Archer Yi Yang, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Transplantation|November 24, 2021
Belatacept in Kidney Transplant Recipients With Failed Allografts for the Prevention of Humoral Sensitization: A Pilot Randomized Controlled TrialI Raul Badell, Robert A Bray, Rivka Elbein, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 4, 2016
Allocating Deceased Donor Kidneys to Candidates with High Panel-Reactive AntibodiesHoward M Gebel, Bertram L Kasiske, Sally K Gustafson, et al.
Clinical Transplantation|February 2, 2022
Immunogenicity after heterologous third dose COVID-19 vaccination in a heart transplant recipientSapna A Mehta, Alex Reyentovich, Robert A Montgomery, et al.
Transplant Immunology|September 24, 2022
Development of donor specific antibodies after SARS-CoV-2 vaccination in kidney and heart transplant recipientsThomas R McCune, Robert A Bray, David A Baran, et al.
Archives of Pathology & Laboratory Medicine|February 25, 2017
Genotyping Applications for Transplantation and Transfusion Management: The Emory ExperienceRoss M Fasano, Harold Cliff Sullivan, Robert A Bray, et al.
Transplantation|April 16, 2004
Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokineticsCarlos A Vieira, Avinash Agarwal, Benita K Book, et al.
Transplantation|September 7, 2022
Analysis of Cross-sectional and Longitudinal HLA and Anti-viral Responses After COVID Infection in Renal Allograft Recipients: Differences and CorrelatesAlin L Girnita, Lin Wang, Adriana I Colovai, et al.
Kidney International|February 16, 2020
Epitopes as characterized by antibody-verified eplet mismatches determine risk of kidney transplant lossRuth Sapir-Pichhadze, Xun Zhang, Abdelhakim Ferradji, et al.
Transplantation Direct|July 17, 2023
Detailed Analysis of Simultaneous Renal and Liver Allografts in the Presence of DSAJacqueline G O'Leary, Alton B Farris, Howard M Gebel, et al.
Frontiers in Immunology|December 12, 2022
Dissecting the impact of molecular T-cell HLA mismatches in kidney transplant failure: A retrospective cohort studyWilliam Lemieux, David Fleischer, Archer Yi Yang, et al.
Pageof 9